» Articles » PMID: 36397823

Efficient Derivation and Banking of Clinical-grade Human Embryonic Stem Cell Lines in Accordance with Japanese Regulations

Overview
Journal Regen Ther
Date 2022 Nov 18
PMID 36397823
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We recently established clinical-grade human embryonic stem cell (hESC) line KthES11 in accordance with current good manufacturing practice standards in Japan. Despite this success, the establishment efficiency was very low at 7.1% in the first period.

Methods: To establish clinical-grade hESC lines, we used xeno-free chemically defined medium StemFit AK03N with the LM-E8 fragments instead of feeder cells. The protocol was then optimized, especially in the early culture phase.

Results: We established five hESC lines (KthES12, KthES13, KthES14, KthES15, and KthES16) with 45.5% efficiency. All five hESC lines showed typical hESC-like morphology, a normal karyotype, pluripotent state, and differentiation potential for all three germ layers. Furthermore, we developed efficient procedures to prepare master cell stocks for clinical-grade hESC lines and an efficient strategy for quality control testing.

Conclusions: Our master cell stocks of hESC lines may contribute to therapeutic applications using human pluripotent stem cells in Japan and other countries.

Citing Articles

ROR2 expression predicts human induced pluripotent stem cell differentiation into neural stem/progenitor cells and GABAergic neurons.

Kuroda T, Yasuda S, Matsuyama S, Miura T, Sawada R, Matsuyama A Sci Rep. 2024; 14(1):690.

PMID: 38184695 PMC: 10771438. DOI: 10.1038/s41598-023-51082-4.


Truncated vitronectin with E-cadherin enables the xeno-free derivation of human embryonic stem cells.

Souralova T, Hulinova D, Jeseta M, Ventruba P, Hampl A, Koutna I Sci Rep. 2023; 13(1):15062.

PMID: 37700192 PMC: 10497536. DOI: 10.1038/s41598-023-42236-5.

References
1.
Andrews P, Baker D, Benvinisty N, Miranda B, Bruce K, Brustle O . Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med. 2015; 10(2 Suppl):1-44. DOI: 10.2217/rme.14.93. View

2.
Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

3.
Miyazaki T, Futaki S, Suemori H, Taniguchi Y, Yamada M, Kawasaki M . Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun. 2012; 3:1236. PMC: 3535336. DOI: 10.1038/ncomms2231. View

4.
Gu Q, Wang J, Wang L, Liu Z, Zhu W, Tan Y . Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations. Stem Cell Reports. 2017; 9(1):366-380. PMC: 5511037. DOI: 10.1016/j.stemcr.2017.04.017. View

5.
Tannenbaum S, Turetsky T, Singer O, Aizenman E, Kirshberg S, Ilouz N . Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications. PLoS One. 2012; 7(6):e35325. PMC: 3380026. DOI: 10.1371/journal.pone.0035325. View